Michel Aguet, Stefania Rigotti, Maximilien Murone, Andres McAllister
Acute myelogenous leukemia (AML) is initiated and maintained by leukemia stem cells (LSC). LSCs are therapy-resistant, cause relapse, and represent a major obstacle for the cure of AML. Resistance to therapy is often mediated by aberrant tyrosine kinase (T ...
Amer Assoc Cancer Research2017